Qaelon Medical Establishes Data Advisory Board to Revolutionize Surgical Leak Detection

Strasbourg, France – June 2025 – Qaelon Medical, a pioneer in real-time surgical leak

detection and constant-flow insufflation technologies, today announced the formation of its Data Advisory Board (DAB) — the first of its kind in the MedTech industry – dedicated

exclusively to data-driven detection, prevention and prediction of surgical leaks. This

multidisciplinary board will be comprised of leading surgeons, data scientists, health

economists, and digital health experts that will define Qaelon’s data strategy with initial

focus on development of a comprehensive open-source dataset on surgical leaks and

gastrointestinal (GI) surgery.

Data-Driven Surgical Leak Detection

The initiative is aligned with Qaelon’s mission to bring data-driven standardization and

transparency to one of the most devastating complications in surgery: intraoperative leaks, In the U.S. alone, 43,000 surgical leaks are reported annually, costing over $1.1 billion in extra treatment. Early leaks carry an 18% mortality rate, double cancer recurrence, and lead to permanent stoma and loss of bowel function in 45% of cases.

“Qaelon’s Data Advisory Board will ensure our technology is optimally deployed to save

lives and reduce healthcare costs by establishing a standardized, data-driven test

methodology for surgical leak detection," ; said Eran Shlomovitz, MD, FRCPC, FRCSC, FACS, Chief Medical Officer and Founder of Qaelon Medical.

"Our platform goes beyond detecting leaks in real-time — we’re bringing the standard for

surgical leak testing into the digital age while expanding the digital ecosystem of the

intelligent OR," added Liam Burns, CEO of Qaelon Medical. "With guidance from our Data Advisory Board, we’re creating the first Objective Performance Indicator (OPI) for surgical leaks, which will enable AI-powered clinical decision support, while advancing a measurable, outcomes-focused standard of care."

Data Advisory Board Members

Qaelon is excited to announce the first two members of our Data Advisory Board: Professor David Jayne and Assistant Professor Amin Madani. These two internationally recognized leaders bring deep expertise in surgical safety, surgical intelligence, and global clinical research.

• David Jayne, MB. BCh., PhD, FRCS, FASCRS​ – Professor, Bowel Cancer UK & RCS (Engl.) Chair of Surgery and Director, Leeds NIHR HealthTech Research Centre, ​

University of Leeds "As a colorectal surgeon and clinical researcher, I’ve seen

firsthand how surgical leaks can derail recovery and compromise outcomes.

Qaelon’s technology introduces the kind of objective intraoperative feedback we’ve

needed for decades — and the company’s data-first approach aligns perfectly with

the future of evidence-based surgical care. I’m excited to help shape this global

registry and ensure it delivers the insights we need to transform clinical practice

and policy."

• Amin Madani, M.D., PhD, FRCSC, FACS – Assistant Professor of Surgery, University of Toronto; Endocrine and Acute Care Surgery, UHN; Director, Surgical Artificial Intelligence Research Academy. “Improving surgical outcomes requires more

than intuition — it demands objective, data-driven insight. Qaelon’s open-source

approach to surgical leak detection represents a critical step toward democratizing

access to real-time intelligence in the OR. By applying data science to one of the

most dangerous complications in surgery, we can elevate surgical performance,

reduce variability, and improve patient safety on a global scale. I’m proud to support

this mission and help advance a new standard of precision surgery.”

Additional members will be announced over the coming weeks.

Data-Driven Vision

Qaelon’s proprietary leak detection system, the first to provide quantifiable, EMR-

exportable leak assessments via a proprietary constant-flow insufflator, delivers objective insights in under 30 seconds. Validated in over 1,200 preclinical tests, it modernizes a century-old workflow, enabling surgeons to identify and address life-threatening leaks in real time to reduce risks of sepsis, reoperation, or death.

The Qaelon Data Advisory Board (DAB), in collaboration with the Scientific Advisory Board, will leverage this platform to lower leak rates and enable predictive analytics, adaptive insufflation protocols, and AI-driven clinical decision support. The DAB’s initial focus includes:

• Creating the world’s first global real-world evidence (RWE) registry for surgical leaks across gastrointestinal, bariatric, thoracic, and urologic procedures using

robotic, endoscopic, and laparoscopic techniques.

• Developing an open-source, vendor-neutral data architecture that integrates with intraoperative technologies like staplers, closure devices, perfusion platforms, energy devices, and imaging systems for comprehensive, data-driven insights.
  

“This open, collaborative approach will shift Qaelon from leak detection to prevention,

saving lives and empowering precision surgery fueled by real-time intelligence,” said Liam Burns, CEO of Qaelon Medical.

About Qaelon Medical

Qaelon Medical is redefining leak detection in surgery. Its platform is the first and only

system that combines real-time, AI-powered detection with precision insufflation, creating the foundation for intraoperative surgical intelligence. Headquartered in Strasbourg, France, Qaelon is backed by industry veterans, strategic partners like Caresyntax, and a global network of clinical innovators.

For more information, visit www.qaelonmedical.com or contact yee-ying.douchamps@qaelonmedical.com.